To investigate whether this unexpected reduction of CD95 expression levels coincided with a decreased sensitivity to CD95-mediated cell death, we next used the anti-CD95 agonist antibody Jo2 at a sub-lethal dose, known to induce a mild hepatitis within 6 h of treatment (Filliol et al, 2017). Here, FAS is linked to hepatitis A virus infection.